{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:03:23Z","timestamp":1777619003376,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.eplepsyres.2005.03.011","type":"journal-article","created":{"date-parts":[[2005,6,27]],"date-time":"2005-06-27T17:07:06Z","timestamp":1119892026000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Autoimmune epilepsy: Distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate\/AMPA receptor GluR3, glutamate\/NMDA receptor subunit NR2A or double-stranded DNA"],"prefix":"10.1016","volume":"65","author":[{"given":"Yonatan","family":"Ganor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadassa","family":"Goldberg-Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tally","family":"Lerman-Sagie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian I.","family":"Teichberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Levite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2005.03.011_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.51.1.302","article-title":"Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis","volume":"51","author":"Antozzi","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib2","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy, 1989. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389\u2013399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib3","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1373\/49.10.1752","article-title":"Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke","volume":"49","author":"Dambinova","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(02)49003-4","article-title":"What is west syndrome?","volume":"49","author":"Dulac","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib6","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1073\/pnas.98.3.1148","article-title":"The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus","volume":"98","author":"Eilat","year":"2001","journal-title":"Proc. Natl. Acad Sci. U.S.A."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib7","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","article-title":"Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration","volume":"170","author":"Ganor","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib8","first-page":"241","article-title":"Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood\u2013brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy","volume":"11","author":"Ganor","year":"2004","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib9","doi-asserted-by":"crossref","unstructured":"Ganor, Y., Freilinger, M., Dulac, O., Levite, M., 2005a Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. Autoimmunity, in press.","DOI":"10.1080\/08916930500100825"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib10","doi-asserted-by":"crossref","unstructured":"Ganor, Y., Goldberg-Stern, H., Blank, M., Shoenfeld, Y., Dobrynina, L.A., Kalashnikova, L., Levite, M., 2005b. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or sneddon's syndrome. Autoimmunity (revised).","DOI":"10.1080\/08916930500246339"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib11","doi-asserted-by":"crossref","unstructured":"Ganor, Y., Gottlieb, M., Eilam, R., Otmy, H., Teichberg, V.I., Levite, M., 2005c. Immunization with the glutamate receptor derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. Exp. Neurol. (in press).","DOI":"10.1016\/j.expneurol.2005.04.002"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000099074.04539.E0","article-title":"Experience with immunomodulatory treatments in Rasmussen's encephalitis","volume":"61","author":"Granata","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJM199805073381906","article-title":"Antibodies to DNA","volume":"338","author":"Hahn","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0896-6273(00)80443-2","article-title":"Glutamate receptor GluR3 antibodies and death of cortical cells","volume":"20","author":"He","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib15","first-page":"11","article-title":"Autoantibodies to a NR2A peptide of the glutamate\/NMDA receptor in sera of patients with systemic lupus erythematosus","volume":"11","author":"Husebye","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI11500","article-title":"LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor","volume":"107","author":"Koustova","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1469-8749.2002.tb00331.x","article-title":"Rasmussen's encephalitis followed by lupus erythematosus","volume":"44","author":"Lascelles","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ni0602-500","article-title":"Autoimmune epilepsy","volume":"3","author":"Levite","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/jaut.1999.0301","article-title":"Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel","volume":"13","author":"Levite","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib20","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1586\/14737175.2.6.809","article-title":"Immunotherapy for epilepsy","volume":"2","author":"Levite","year":"2002","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00261-8","article-title":"Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures","volume":"131","author":"Mantegazza","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.8.6.435","article-title":"Focal seizures due to chronic localized encephalitis","volume":"8","author":"Rasmussen","year":"1958","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib23","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib24","series-title":"Managing Epilepsy and Co-existing Disorders","first-page":"135","article-title":"Inflammatory noninfectious disorders","author":"Seiden","year":"2002"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1212\/01.WNL.0000086819.53078.70","article-title":"Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua","volume":"61","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","article-title":"Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus","volume":"99","author":"Toubi","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0896-6273(95)90219-8","article-title":"Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site","volume":"14","author":"Twyman","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib28","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1523\/JNEUROSCI.20-19-07307.2000","article-title":"GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins","volume":"20","author":"Whitney","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2005.03.011_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.57.8.1511","article-title":"GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis","volume":"57","author":"Wiendl","year":"2001","journal-title":"Neurology"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121105000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:15:02Z","timestamp":1760274902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121105000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0920121105000549"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.03.011","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune epilepsy: Distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate\/AMPA receptor GluR3, glutamate\/NMDA receptor subunit NR2A or double-stranded DNA","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}